Minireviews
Copyright ©The Author(s) 2021.
World J Diabetes. Sep 15, 2021; 12(9): 1507-1517
Published online Sep 15, 2021. doi: 10.4239/wjd.v12.i9.1507
Table 1 Salivary resistin concentration in association with body mass index and the homeostatic model assessment of insulin resistance
Study group
BMI (kg/m2)
Salivary resistin (ng/mL)
Correlation with BMI
Correlation with blood glucose
Correlation with HOMA-IR
Correlation test used
Ref.
Healthy 22.39 ± 3.651.69NS--Partial correlationMamali et al[77]
T2DM25.5 ± 4.93.4± 0.41-0.391-0.14-0.201Pearson’s testYin et al[29]
Control23.9 ± 3.31.5 ± 0.3-0.17-0.281-0.19
T2DM-4 ± 0.451----Sarhat et al[80]
Control-1.73 ± 0.34 ----
Obese diabetic34.3 ± 3.914.7 ± 2.8 Significant NSAl-Rawi and Al-Marzooq[81]
Obese non-diabetic 34.2 ± 2.914.4 ± 3.6Significant
Control “Non-obese-non -diabetic7.1 ± 2.110.8 ± 6.1Significant -
T2DM-9.2 ± 2.31---Srinivasan et al[82]
Control-5.7 ± 1.3---
GDM32 (20.4–43.7)13.11---Gürlek and Çolak[83]
Control 27.2 (19.4–42)5.9---